v3.26.1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Unallocated Common Stock Held by ESOP
Beginning balance (in shares) at Dec. 31, 2024   213,909,472        
Beginning Balance at Dec. 31, 2024 $ 3,611,967 $ 2,141 $ 2,237,494 $ 2,084,503 $ (584,329) $ (127,842)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends to common shareholders [1] (50,194)     (50,194)    
Issuance of restricted stock awards (in shares)   54,236        
Issuance of restricted stock awards 0 $ 1 (1)      
Repurchased common stock (in shares)   (3,058,583)        
Repurchased common stock (51,929) $ (30) (51,899)      
Restricted share awards cancelled (in shares) [2]   (10,954)        
Restricted share awards cancelled [2] (147) $ (2) (145)      
Issuance of common stock under share-based compensation arrangements (in shares) [3]   569,125        
Issuance of common stock under share-based compensation arrangements [3] (6,238) $ 5 (6,243)      
Share-based compensation 8,997   8,997      
Net income (loss) (117,433)     (117,433)    
Other comprehensive income, net of tax 284,802       284,802  
ESOP shares committed to be released 4,066   1,524     2,542
Ending balance (in shares) at Jun. 30, 2025   211,463,296        
Ending balance at Jun. 30, 2025 3,683,891 $ 2,115 2,189,727 1,916,876 (299,527) (125,300)
Beginning balance (in shares) at Mar. 31, 2025   211,560,177        
Beginning Balance at Mar. 31, 2025 3,582,934 $ 2,116 2,188,552 1,842,607 (323,779) (126,562)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends to common shareholders [4] (25,964)     (25,964)    
Issuance of restricted stock awards (in shares)   54,236        
Issuance of restricted stock awards 0 $ 1 (1)      
Repurchased common stock (in shares)   (183,053)        
Repurchased common stock (3,272) $ (2) (3,270)      
Restricted share awards cancelled (in shares) [5]   (519)        
Restricted share awards cancelled [5] (8)   (8)      
Issuance of common stock under share-based compensation arrangements (in shares) [6]   32,455        
Issuance of common stock under share-based compensation arrangements [6] (402)   (402)      
Share-based compensation 4,245   4,245      
Net income (loss) 100,233     100,233    
Other comprehensive income, net of tax 24,252       24,252  
ESOP shares committed to be released 1,873   611     1,262
Ending balance (in shares) at Jun. 30, 2025   211,463,296        
Ending balance at Jun. 30, 2025 $ 3,683,891 $ 2,115 2,189,727 1,916,876 (299,527) (125,300)
Beginning balance (in shares) at Dec. 31, 2025 235,646,558 235,646,558        
Beginning Balance at Dec. 31, 2025 $ 4,340,553 $ 2,356 2,621,029 2,067,327 (227,363) (122,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends to common shareholders [1] (61,765)     (61,765)    
Issuance of restricted stock awards (in shares)   58,245        
Issuance of restricted stock awards 0 $ 1 (1)      
Repurchased common stock (in shares)   (7,512,620)        
Repurchased common stock (149,205) $ (75) (149,130)      
Restricted share awards cancelled (in shares) [2]   (6,031)        
Restricted share awards cancelled [2] (122)   (122)      
Issuance of common stock under share-based compensation arrangements (in shares) [3]   363,944        
Issuance of common stock under share-based compensation arrangements [3] (4,080) $ 4 (4,084)      
Share-based compensation 8,597   8,597      
Stock options exercised (in shares)   308,268        
Stock options exercised 4,125 $ 3 4,122      
Net income (loss) 170,475     170,475    
Other comprehensive income, net of tax (30,434)       (30,434)  
ESOP shares committed to be released $ 5,070   2,546     2,524
Ending balance (in shares) at Jun. 30, 2026 228,858,364 228,858,364        
Ending balance at Jun. 30, 2026 $ 4,283,214 $ 2,289 2,482,957 2,176,037 (257,797) (120,272)
Beginning balance (in shares) at Mar. 31, 2026   232,292,219        
Beginning Balance at Mar. 31, 2026 4,285,980 $ 2,323 2,549,369 2,103,663 (247,848) (121,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends to common shareholders [4] (32,839)     (32,839)    
Issuance of restricted stock awards (in shares)   58,245        
Issuance of restricted stock awards 0 $ 1 (1)      
Repurchased common stock (in shares)   (3,629,154)        
Repurchased common stock (73,700) $ (36) (73,664)      
Restricted share awards cancelled (in shares) [5]   (524)        
Restricted share awards cancelled [5] (3)   (3)      
Issuance of common stock under share-based compensation arrangements (in shares) [6]   10,186        
Issuance of common stock under share-based compensation arrangements [6] (91)   (91)      
Share-based compensation 4,439   4,439      
Stock options exercised (in shares)   127,392        
Stock options exercised 1,704 $ 1 1,703      
Net income (loss) 105,213     105,213    
Other comprehensive income, net of tax (9,949)       (9,949)  
ESOP shares committed to be released $ 2,460   1,205     1,255
Ending balance (in shares) at Jun. 30, 2026 228,858,364 228,858,364        
Ending balance at Jun. 30, 2026 $ 4,283,214 $ 2,289 $ 2,482,957 $ 2,176,037 $ (257,797) $ (120,272)
[1] The Company declared cumulative cash dividends of $0.28 and $0.25 per share of common stock during the six months ended June 30, 2026 and 2025, respectively.
[2] Represents restricted stock awards (“RSAs”) cancelled upon vesting for employee payroll tax withholding and upon forfeiture.
[3] Represents shares issued, net of employee tax withheld, upon the vesting of restricted stock units. Refer to Note 9, “Employee Benefits” for additional discussion.
[4] The Company declared quarterly cash dividends of $0.15 and $0.13 per share of common stock during the three months ended June 30, 2026 and 2025, respectively.
[5] Represents restricted stock awards (“RSAs”) cancelled upon vesting for employee payroll tax withholding and upon forfeiture.
[6] Represents shares issued, net of employee tax withheld, upon the vesting of restricted stock units. Refer to Note 9, “Employee Benefits” for additional discussion.